Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No significant changes detected; the page content remains the same, with only minor visual differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:37:10.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Page updated to v3.2.0 with a new government-operating status notice; previous version v3.1.0 reference removed. Core content remains, but timing/operational details are updated.
    Difference
    3%
    Check dated 2025-10-06T04:53:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page mainly updates the version tag to v3.1.0 and removes a prior version tag (v3.0.2); a reference to Dense deposit disease is also removed. No substantive changes to core content, pricing, or key entities are evident.
    Difference
    0.2%
    Check dated 2025-09-29T02:55:33.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link — a small, mostly UI-focused update.
    Difference
    0.2%
    Check dated 2025-09-14T18:51:34.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:32:37.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional drug information and publications, while removing outdated location terms and certain genetic disease resources.
    Difference
    7%
    Check dated 2025-08-31T11:28:30.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.